Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Dihydroartemisinin + Piperaquine
- Therapeutic area
- Anti-infectives
- Drug class
- Antimalarials
- ATC
- P01BF
- Strength
- 40 mg + 320 mg
- Dosage form
- Tablet
- Pack
- 8's
- Registration no.
- 109415
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Hedqin 40 (Dihydroartemisinin + piperaquine) is used for
Dihydroartemisinin and piperaquine are two antimalarial medicines combined in one tablet. Dihydroartemisinin (an artemisinin medicine) acts fast to clear malaria parasites from the blood. Piperaquine acts for longer, to clear the parasites that are left and to help protect against catching malaria again for a while. Using two medicines together also lowers the chance that the parasites become resistant. It is a prescription medicine, and the World Health Organization (WHO) has approved (prequalified) versions of this tablet.
- Uncomplicated malaria (malaria that has not become severe), especially malaria caused by the falciparum parasite
- The WHO product information says it works against all the malaria parasites that infect people, while the European physician guide lists it for falciparum malaria only and not for vivax, malariae or ovale. A doctor decides which one applies to you.
- It can be used in adults, children and infants, as set out in the product information
Get medical help straight away if
- Get urgent medical help for a fast, pounding or uneven heartbeat, or any serious heart rhythm problem. This medicine can lengthen the QT interval of the heartbeat, which can very rarely lead to dangerous rhythm problems.
- Get urgent help if a child has a fit (convulsion).
- Get urgent help for signs of a severe allergic reaction, such as swelling of the face, lips, tongue or throat, or trouble breathing.
- See a doctor quickly if you become very pale, tired or breathless, or your skin or eyes turn yellow. Anaemia caused by red blood cells breaking down has been reported some time after treatment, and jaundice needs checking.
Side effects, warnings and interactions for Dihydroartemisinin + piperaquine
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
Our condition guides that mention Dihydroartemisinin + Piperaquine
From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Dihydroartemisinin + Piperaquine is right for you and the dose.
- Malaria: first-choice treatment for uncomplicated falciparum malaria
About Hedqin 40 40 mg + 320 mg tablet
Hedqin 40 40 mg + 320 mg tablet contains Dihydroartemisinin + Piperaquine 40 mg + 320 mg. It is registered with DRAP by M/s Daneen Pharma (Pvt) Ltd (registration no. 109415). Its official price is PKR 676.29 for a pack of 8's, about PKR 84.54 per tablet. This price has applied since 22 July 2026. 8 other brands of Dihydroartemisinin + Piperaquine 40 mg + 320 mg (tablet) are registered in Pakistan. Compare all brands and prices →
All 8 other brands of Dihydroartemisinin + Piperaquine 40 mg + 320 mg tablet in Pakistan
These 8 brands are alternatives (substitutes) to Hedqin 40: each contains Dihydroartemisinin + Piperaquine 40 mg + 320 mg tablet. Ask your doctor or pharmacist before you switch brands.
Sorted by price per tablet, lowest first. The lowest is DIPIP (Hilton Pharma (Pvt) Limited) at PKR 78.49 per tablet; the highest is Hitecxin ACT at PKR 93.63. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| DIPIP | Hilton Pharma (Pvt) Limited | 8's | PKR 627.91 | PKR 78.49 / tablet |
| Diphos | M/s. Genix Pharma (Pvt) Ltd | 8's | PKR 644.27 | PKR 80.53 / tablet |
| Maldip | Aspin Pharma | 8's | PKR 670.67 | PKR 83.83 / tablet |
| Tess 40 | Hiranis Pharmaceuticals Pvt. Ltd | 8's | PKR 676.25 | PKR 84.53 / tablet |
| EUARIA | Martin Dow Limited | 8's | PKR 676.33 | PKR 84.54 / tablet |
| PIPRA | Atco Laboratories Limited | 8's | PKR 680.22 | PKR 85.03 / tablet |
| ARTEQUINE | Platinum Pharmaceuticals | 8'S | PKR 698.39 | PKR 87.30 / tablet |
| Hitecxin ACT | Highnoon Laboratories Ltd | 8 | PKR 749.01 | PKR 93.63 / tablet |
See every strength and form of Dihydroartemisinin + Piperaquine →
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Hedqin 40, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- M/s Daneen Pharma (Pvt) Ltd, Lahore
- DRAP registration
- 109415
- Phone
- +92 21 111 10 10 11
- Website
- https://daneenpharma.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (8's). Current price PKR 676.29, effective 22 Jul 2026.
Cite this price history
MedInfoBase. Hedqin 40 40 mg + 320 mg, 8's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/hedqin-40-40-mg-320-mg-109415-8s-m-s-daneen-pharma-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 676.29 | 2026-07-22 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 109415Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.